Pharming Group NV (PHAR)
12.28
-0.31
(-2.46%)
USD |
NASDAQ |
Jun 10, 16:00
12.59
+0.31
(+2.52%)
Pre-Market: 20:00
Pharming Group Market Cap : 861.32M for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 861.32M |
| June 09, 2026 | 883.07M |
| June 08, 2026 | 897.80M |
| June 05, 2026 | 879.64M |
| June 04, 2026 | 874.65M |
| June 03, 2026 | 858.52M |
| June 02, 2026 | 861.32M |
| June 01, 2026 | 918.84M |
| May 29, 2026 | 911.12M |
| May 28, 2026 | 958.12M |
| May 27, 2026 | 918.78M |
| May 26, 2026 | 933.17M |
| May 22, 2026 | 863.29M |
| May 21, 2026 | 877.67M |
| May 20, 2026 | 881.79M |
| May 19, 2026 | 863.29M |
| May 18, 2026 | 864.66M |
| May 15, 2026 | 885.21M |
| May 14, 2026 | 887.95M |
| May 13, 2026 | 888.64M |
| May 12, 2026 | 896.86M |
| May 11, 2026 | 864.90M |
| May 08, 2026 | 889.32M |
| May 07, 2026 | 822.18M |
| May 06, 2026 | 1.124B |
| Date | Value |
|---|---|
| May 05, 2026 | 1.108B |
| May 04, 2026 | 1.123B |
| May 01, 2026 | 1.163B |
| April 30, 2026 | 1.133B |
| April 29, 2026 | 1.121B |
| April 28, 2026 | 1.125B |
| April 27, 2026 | 1.159B |
| April 24, 2026 | 1.143B |
| April 23, 2026 | 1.140B |
| April 22, 2026 | 1.170B |
| April 21, 2026 | 1.174B |
| April 20, 2026 | 1.204B |
| April 17, 2026 | 1.188B |
| April 16, 2026 | 1.187B |
| April 15, 2026 | 1.220B |
| April 14, 2026 | 1.211B |
| April 13, 2026 | 1.162B |
| April 10, 2026 | 1.171B |
| April 09, 2026 | 1.163B |
| April 08, 2026 | 1.163B |
| April 07, 2026 | 1.125B |
| April 06, 2026 | 1.130B |
| April 02, 2026 | 1.139B |
| April 01, 2026 | 1.159B |
| March 31, 2026 | 1.140B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProQR Therapeutics NV | 148.56M |
| NewAmsterdam Pharma Co. NV | 3.421B |
| ACADIA Pharmaceuticals, Inc. | 3.636B |
| Alkermes Plc | 7.298B |
| Alnylam Pharmaceuticals, Inc. | 38.86B |
Market Cap Related Metrics
| PE Ratio | 71.27 |
| PS Ratio | 2.344 |
| Price to Book Value | 3.202 |
| Price to Free Cash Flow | 17.12 |
| Price | 12.28 |
| Earnings Yield | 1.40% |
| Operating PE Ratio | 27.49 |
| Normalized PE Ratio | 44.77 |